Jefferies upgraded AstraZeneca (NYSE: AZN) from Underperform to Hold with a 3,080p price target as management look to better defend ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE